Last Updated:
Name Designation Appointment Date Status
Jayan Padmanabhan

Appointed as Director since March 2012

Director 30-Mar-2012 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Lycus Pharma Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Lathish Pulickaparambil Narayanan Nair

Appointed as Managing Director since March 2012

Managing Director 30-Mar-2012 Current
Jacob Job

Appointed as Director since March 2012

Director 30-Mar-2012 Current
Jose Joseph

Appointed as Director since July 2009

Director 06-Jul-2009 Current

People Timeline

Explore the timeline of key personnel in Lycus Pharma Private Limited's leadership journey.

Loading...
Contact Details
  • Address Xiii/331/1, Anjiliveeliyil Building, Near Ymca, Tiruvalla Kerala, 689101, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 689101
  • Country India
  • Website -
Frequently Asked Questions
You can contact Lycus Pharma Private Limited through their registered address at Xiii/331/1, Anjiliveeliyil Building, Near Ymca, Tiruvalla Kerala, 689101, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Lycus Pharma Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • JAYAN PADMANABHAN
  • LATHISH PULICKAPARAMBIL NARAYANAN NAIR
  • JACOB JOB
  • JOSE JOSEPH
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available